umeclidinium

FDA Drug Profile — Umeclidinium Ellipta, Incruse Ellipta

umeclidinium is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Umeclidinium Ellipta, Incruse Ellipta. Available dosage form: aerosol, powder.

Drug details

Generic Name
umeclidinium
Brand Names
Umeclidinium Ellipta, Incruse Ellipta
Application Number
NDA205382
Sponsor
Prasco Laboratories
NDC Codes
2
Dosage Forms
AEROSOL, POWDER
Routes
ORAL
Active Ingredients
UMECLIDINIUM BROMIDE

Indications and Usage

1 INDICATIONS AND USAGE Umeclidinium ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Umeclidinium ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.